PSNL - Personalis Inc
Personalis Inc Logo

PSNL - Personalis Inc

https://www.personalis.com
Buy Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Range-Bound
As of 2025-09-10 (Snapshot)

Personalis, Inc. is a global cancer genomics company. The company is headquartered in Menlo Park, California.

52W High
$7.79
52W Low
$2.83

MA Status:
50D: Below 200D: Above
Beta (~1 neutral, <0.9 lower risk)
1.77
Valuation
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
-0.03
EV/Revenue (<3 favorable)
4.16
P/S (TTM) (<3 favorable)
5.79
P/B (<3 favorable)
2.44
Ownership
Balanced
Source: Overview
Insiders (1–5% typical)
31.36%
Institutions (25–75% balanced)
52.26%
Shares Outstanding
88,677,000
Float
52,594,000
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
80,317,000
Gross Profit (TTM)
25,258,000
EPS (TTM)
-1.28
Profit Margin (>10% good)
-1.14%
Operating Margin (TTM) (higher better)
-1.27%
ROE (TTM) (>15% strong)
-0.60%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
-0.24
Momentum
Bearish momentum
Value
-0.1134
Previous
-0.1667
Trend
Rising
Signal Cross
No cross

As of
Sep. 05, 2025